Literature DB >> 15261144

p63 and p73 are not required for the development and p53-dependent apoptosis of T cells.

Makoto Senoo1, John P Manis, Frederick W Alt, Frank McKeon.   

Abstract

The recent discoveries of p63 and p73, homologs of the tumor suppressor p53, raised the possibility of a network of these family members governing cell cycle arrest and apoptosis in response to stress. However, mice lacking p73 show no tendency for spontaneous tumors, and mutations in p63 or p73 are rare in human tumors, rendering any obligate role of these genes in cell death and tumor suppression unclear. In an effort to reconcile these incongruent data, we examined the genetic interactions between p53, p63, and p73 in well-established paradigms of p53-dependent and -independent T cell death using primary, genetically defined lymphocytes. Our findings challenge the generality of the notion that p63 and p73 are required for p53 function or for apoptosis in T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261144     DOI: 10.1016/j.ccr.2004.06.005

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  28 in total

1.  Differential recognition of response elements determines target gene specificity for p53 and p63.

Authors:  Motonobu Osada; Hannah Lui Park; Yuichi Nagakawa; Keishi Yamashita; Alexey Fomenkov; Myoung Sook Kim; Guojun Wu; Shuji Nomoto; Barry Trink; David Sidransky
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

2.  The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63.

Authors:  E S Helton; J Zhang; X Chen
Journal:  Oncogene       Date:  2007-11-26       Impact factor: 9.867

3.  Mechanisms of regulatory diversity within the p53 transcriptional network.

Authors:  J M Espinosa
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

4.  p53-independent apoptosis limits DNA damage-induced aneuploidy.

Authors:  Laura M McNamee; Michael H Brodsky
Journal:  Genetics       Date:  2009-04-13       Impact factor: 4.562

Review 5.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

6.  The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

7.  The Roles of P53 and Its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis-Stage Mouse Embryos.

Authors:  Nazem El Husseini; Barbara F Hales
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 8.  Tumor suppression by p53: making cells senescent.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Histol Histopathol       Date:  2010-04       Impact factor: 2.303

Review 9.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

Review 10.  p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis.

Authors:  Xiaohua Su; Deepavali Chakravarti; Elsa R Flores
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.